0001593968-21-002287.txt : 20211021 0001593968-21-002287.hdr.sgml : 20211021 20211021171338 ACCESSION NUMBER: 0001593968-21-002287 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210125 FILED AS OF DATE: 20211021 DATE AS OF CHANGE: 20211021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER ANDREW B CENTRAL INDEX KEY: 0001285221 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 211337857 BUSINESS ADDRESS: STREET 1: 440 CLYDE AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509305282 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-01-25 0000738214 AEMETIS, INC AMTX 0001285221 FOSTER ANDREW B 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 false true false false Executive Vice President Common Stock 2021-04-22 4 F false 4683 18.58 D 23862 D Common Stock 2021-04-19 4 F false 10500 18.99 D 221404 D Common Stock 2021-04-22 4 F false 1350 18.58 D 32382 D Common Stock 2021-04-19 4 F false 9058 18.99 D 153404 D Common Stock 2021-01-27 4 S false 15000 7.77 D 5235 D Common Stock 2021-01-28 4 S false 10000 7.5517 D 5235 D Common Stock 2021-01-29 4 S false 10000 6.57 D 5235 D Common Stock 2021-02-01 4 S false 10000 7.91 D 5235 D Common Stock 2021-02-02 4 S false 5000 7.53 D 5235 D Common Stock 2021-03-15 4 F false 1681 20.83 D 53554 D Common Stock 2021-02-02 4 S false 5000 8 D 5235 D Common Stock 2021-02-03 4 S false 10000 7.53 D 5235 D Common Stock 2021-02-04 4 S false 10000 7.86 D 5235 D Common Stock 2021-02-05 4 S false 10000 7.45 D 5235 D Common Stock 2021-02-08 4 S false 10000 7.59 D 5235 D Common Stock 2021-01-26 4 S false 5000 9.0422 D 5235 D Common Stock 2021-03-16 4 F false 1112 19.21 D 90361 D Common Stock 2021-04-19 4 F false 1696 18.99 D 254708 D Common Stock 2021-04-19 4 F false 1887 18.99 D 45190 D Common Stock 2021-03-15 4 F false 1081 20.83 D 89973 D Common Stock 2021-04-22 4 F false 1664 18.58 D 40718 D Common Stock 2021-01-25 4 S false 10000 7.55 D 5235 D Common Stock 2021-03-15 4 S false 29000 19.9231 D 60973 D Common Stock 2021-03-16 4 S false 32800 19.5437 D 57561 D Common Stock 2021-03-17 4 S false 52150 18.9162 D 5411 D Common Stock 2021-04-19 4 F false 2728 18.99 D 62462 D Common Stock 2021-04-19 4 S false 236163 18.6479 D 18545 D Common Stock 2021-04-20 4 S false 10000 17.7075 D 8545 D Common Stock 2021-04-22 4 S false 32170 19.3969 D 8548 D These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock. These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. These shares were sold pursuant to a Rule 10b5-1 plan. /s/Todd Waltz attorney-infact 2021-10-21